Immune Response to Primary KSHV Infection in ART Treated HIV+ Zambian Children

Ronald T Mitsuyasu

AIDS Malignancy Clinical Trials Consortium (AMC)

Trachea, bronchus and lung Other pharynx Oesophagus Non-Hodgkin lymphoma Nasopharynx Liver and intrahepatic bile ducts Kidney, renal pelvis and ureter Kaposi sarcoma Hodgkin lymphoma Colorectum Cervix uteri

Theodore S Jardetzky

Inhibitors of the Epstein-Barr Virus Entry Machinery

Trachea, bronchus and lung Other pharynx Oesophagus Non-Hodgkin lymphoma Nasopharynx Kaposi sarcoma Hodgkin lymphoma

John Nicholas

BH3-only Protein Targeting by HHV-8

Non-Hodgkin lymphoma Kaposi sarcoma Hodgkin lymphoma

Pathology

Julie McElrath

Cape Town HVTN Immunology Laboratory

Kaposi sarcoma Colorectum Cervix uteri Brain, nervous system

Dirk P Dittmer

Regulation of the KSHV Latent Promoter

Non-Hodgkin lymphoma Kaposi sarcoma

Alfred Neugut

Columbia-South Africa Training Program for Research on Hiv-Associated Malignanci

Non-Hodgkin lymphoma Kaposi sarcoma

Jeffery N Martin

Uganda-UCSF Research Training in HIV-Associated Malignancies

Kaposi sarcoma

Pathology

Vincent DeGennaro

National Cancer Treatment Program

Stomach Ovary Non-Hodgkin lymphoma Nasopharynx Leukaemia Larynx Kaposi sarcoma Hodgkin lymphoma Colorectum Breast

Norman E Sharpless

Cancer Center Core Support Grant

Trachea, bronchus and lung Prostate Pancreas Other pharynx Non-Hodgkin lymphoma Nasopharynx Melanoma of skin Liver and intrahepatic bile ducts Leukaemia Kidney, renal pelvis and ureter Kaposi sarcoma Colorectum Cervix uteri Breast